Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Zhonghua Yi Xue Za Zhi|January 6, 2005
[Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection]Wen-hua Piao, Yu He, Hong-li Xi, et al.
Protein Expression and Purification|May 12, 2004
Cloning, expression, and purification of HLA-A2-BSP and beta-2m in Escherichia coliWen-Hua Piao, Xiao-Guo Song, Mao-Chang Liu, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|April 26, 2007
[The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients]Heng-hui Zhang, Ran Fei, Ming-hui Mei, et al.
International Journal of Oncology|February 13, 2009
Expression of CIITA-related MHCII molecules in tumors linked to prognosis in hepatocellular carcinomaXing-Wang Xie, Ming-Hui Mei, Wei-Jia Liao, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|September 5, 2012
[Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]Yan Wang, Heng-hui Zhang, Yan-hui Chen, et al.
Antiviral Therapy|June 7, 2012
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutationsXue-Yan Wang, Zhen-Man Wei, Guo-Yi Wu, et al.
Hepatology International|April 7, 2025
Diverse approaches and sources to derive antitumor T cell for liver cancer: a single-cell sequence based researchAi-Xian Zhang, Jia-Rui Chen, Ai-Rong Yang, et al.
Thoracic Cancer|September 7, 2021
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancerHui-Bo Feng, Yu Chen, Zhi Xie, et al.
Frontiers in Immunology|October 20, 2022
PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinomaYu-Min Zhong, Kai Yin, Yu Chen, et al.
Pageof 3